WSFS
SUPN icon

Wilmington Savings Fund Society’s Supernus Pharmaceuticals SUPN Stock Holding History

Wilmington Savings Fund Society’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.3K Hold
500
– – ﹤0.01% 1051
2026
Q1 		$25.8K Buy
500
+200
+67% +$10.2K ﹤0.01% 1014
2025
Q4 		$14.9K Buy
+300
New +$14.6K ﹤0.01% 1125

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Wilmington Savings Fund Society's SUPN Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 500 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Wilmington Savings Fund Society first reported a position in SUPN in Q4 2025 and has held it in 3 quarters since. The position peaked at $25.8K in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Wilmington Savings Fund Society held 500 shares of Supernus Pharmaceuticals worth $23.3K as of Q2 2026.
  • Wilmington Savings Fund Society left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1051 holding.
  • Wilmington Savings Fund Society first reported a position in Supernus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Wilmington Savings Fund Society's Supernus Pharmaceuticals position peaked at $25.8K in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.